These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 2692971)
1. A double-blind clinical trial of fenticonazole (2%) spray versus naftifine (1%) spray in patients with cutaneous mycoses. Leiste D; Braun W; Fegeler W; Fegeler K; Stary A; Ruping KW; Klaschka F; Colli E; Sartani A Curr Med Res Opin; 1989; 11(9):567-75. PubMed ID: 2692971 [TBL] [Abstract][Full Text] [Related]
2. Topical fenticonazole in dermatology and gynaecology: current role in therapy. Veraldi S; Milani R Drugs; 2008; 68(15):2183-94. PubMed ID: 18840006 [TBL] [Abstract][Full Text] [Related]
3. [Multicenter double-blind contralateral comparison of naftifin and clotrimazole cream in patients with dermatophytosis and candidiasis]. Zaun H; Luszpinski P Z Hautkr; 1984 Sep; 59(18):1209-17. PubMed ID: 6388169 [TBL] [Abstract][Full Text] [Related]
4. Naftifine cream 1% versus clotrimazole cream 1% in the treatment of tinea pedis. Naftifine Podiatric Study Group. J Am Podiatr Med Assoc; 1990 Jun; 80(6):314-8. PubMed ID: 2189989 [TBL] [Abstract][Full Text] [Related]
5. Effect of fenticonazole spray in cutaneous mycosis: a double-blind clinical trial versus cyclopyroxolamine spray. Altmeyer P; Nolting S; Kuhlwein A; Colli E; Scatigna M J Int Med Res; 1990; 18(1):61-7. PubMed ID: 2185965 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of naftifine HCl Gel 2% in the treatment of interdigital and moccasin type tinea pedis: pooled results from two multicenter, randomized, double-blind, vehicle-controlled trials. Stein Gold LF; Parish LC; Vlahovic T; Plaum S; Kircik L; Fleischer AB; Verma A; Olayinka B; Hardas B J Drugs Dermatol; 2013 Aug; 12(8):911-8. PubMed ID: 23986165 [TBL] [Abstract][Full Text] [Related]
7. Fenticonazole cream once daily in dermatomycosis, a double-blind controlled trial versus bifonazole. Jung EG; Bisco A; Azzollini E; Sartani A; Ruffmann R Dermatologica; 1988; 177(2):104-8. PubMed ID: 3049173 [TBL] [Abstract][Full Text] [Related]
8. Naftifine cream in the treatment of cutaneous candidiasis. Zaias N; Astorga E; Cordero CN; Day RM; de Espinoza ZD; DeGryse R; Rojas RF; Sefton J Cutis; 1988 Sep; 42(3):238-40. PubMed ID: 3048914 [TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the efficacy of a new antimycotic molecule for topical use: naftifine]. Albanese G; Giorgetti P; Santagostino L; Di Cintio R; Colombo MD G Ital Dermatol Venereol; 1989 May; 124(5):XXXIII-XXXVII. PubMed ID: 2620916 [TBL] [Abstract][Full Text] [Related]
10. [Double blind, randomized in vivo investigations comparing the antifungals clotrimazole, tolnaftate and naftifine (author's transl)]. Hantschke D; Reichenberger M Mykosen; 1980 Dec; 23(12):657-68. PubMed ID: 7012610 [No Abstract] [Full Text] [Related]
11. [The antifungal agent naftifin. Placebo-controlled therapeutic comparison in tinea pedis]. Klaschka F; Gartmann H; Weidinger G Z Hautkr; 1984 Sep; 59(18):1218-26. PubMed ID: 6388170 [TBL] [Abstract][Full Text] [Related]
12. A double-blind, randomized, vehicle-controlled study evaluating the efficacy and safety of naftifine 2% cream in tinea cruris. Parish LC; Parish JL; Routh HB; Avakian E; Olayinka B; Pappert EJ; Plaum S; Fleischer AB; Hardas B J Drugs Dermatol; 2011 Oct; 10(10):1142-7. PubMed ID: 21968664 [TBL] [Abstract][Full Text] [Related]
13. Optimizing topical antifungal therapy for superficial cutaneous fungal infections: focus on topical naftifine for cutaneous dermatophytosis. Del Rosso JQ; Kircik LH J Drugs Dermatol; 2013 Nov; 12(11 Suppl):s165-71. PubMed ID: 24196340 [TBL] [Abstract][Full Text] [Related]
14. Naftifine cream 1% versus econazole cream 1% in the treatment of tinea cruris and tinea corporis. Millikan LE; Galen WK; Gewirtzman GB; Horwitz SN; Landow RK; Nesbitt LT; Roth HL; Sefton J; Day RM J Am Acad Dermatol; 1988 Jan; 18(1 Pt 1):52-6. PubMed ID: 3279083 [TBL] [Abstract][Full Text] [Related]
15. Naftifine Hydrochloride Gel 2%: An Effective Topical Treatment for Moccasin-Type Tinea Pedis. Stein Gold LF; Vlahovic T; Verma A; Olayinka B; Fleischer AB J Drugs Dermatol; 2015 Oct; 14(10):1138-44. PubMed ID: 26461826 [TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, vehicle-controlled efficacy and safety study of naftifine 2% cream in the treatment of tinea pedis. Parish LC; Parish JL; Routh HB; Fleischer AB; Avakian EV; Plaum S; Hardas B J Drugs Dermatol; 2011 Nov; 10(11):1282-8. PubMed ID: 22052309 [TBL] [Abstract][Full Text] [Related]
17. Double-blind randomized comparative study of naftifine cream and clotrimazole cream in the treatment of dermatophytosis. el Darouti MA; al Raubaie S; Shandrashekhar CR; al Sawaf MH; Movahadi GA Int J Dermatol; 1989 Jun; 28(5):345-6. PubMed ID: 2753593 [No Abstract] [Full Text] [Related]
18. Clinical evaluation of fenticonazole cream in cutaneous fungal infections: a comparison with miconazole cream. Athow-Frost TA; Freeman K; Mann TA; Marks R; Vollum D; Warin AP Curr Med Res Opin; 1986; 10(2):107-16. PubMed ID: 3709210 [TBL] [Abstract][Full Text] [Related]
19. Once-daily naftifine cream 1% in the treatment of tinea cruris and tinea corporis. Jordon RE; Rapini RP; Rex IH; Katz HI; Hickman JG; Bard JW; Medansky RS; Lew-Kaya DA; Sefton J; DeGryse RE Int J Dermatol; 1990; 29(6):441-2. PubMed ID: 2397973 [TBL] [Abstract][Full Text] [Related]
20. Naftifine. A review of its antimicrobial activity and therapeutic use in superficial dermatomycoses. Monk JP; Brogden RN Drugs; 1991 Oct; 42(4):659-72. PubMed ID: 1723367 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]